Valicherla GR, Hossain Z, Mahata SK, Gayen JR. Pancreastatin is an endogenous peptide that regulates glucose homeostasis.
CHROMOGRANIN A (CHGA) is a uniquely acidic, heat-stable and soluble protein that is ubiquitous in secretory cells of the nervous, endocrine, and immune system (31, 90) . The human chromogranin A (hCHGA) gene is known to be homologous with a portion of mouse chromosome 12 (between Igh-C and D12Pas1 in different species), rat chromosome 6, and bovine chromosome 21 (75) . The hCHGA gene is located on chromosome 14q32.12, which spans 12,192 bp and gives rise to a transcript of 2,041 bp that encodes a 439-amino acid (aa) mature protein (85) . There are 10 dibasic sites in hCHGA, which are potential sites of proteolytic cleavage (37) . The hCHGA gene is organized in eight exons and seven introns (5, 82) (Fig. 1) . Exon VII encodes most of the biologically active peptides including dysglycemic hormone pancreastatin (PST). CHGA upon proteolysis gives a variety of biologically active peptides like PST, betagranin, vasostatin-I, vasostatin-II, parastatin, prochromacin, chromacin, and catestatin (44) .
One of these peptides, PST inhibits the rapid phase of insulin release when the rat pancreas is stimulated with glucose (11) . In the profusion rat pancreas, PST can inhibit not only glucoseinduced insulin release but also insulin release in response to arginine, tolbutamide, vasoactive intestinal peptide (VIP), gastric inhibitory peptide (GIP), and cholecystokinin (CCK-8) (11) . In islets, PST appears to be localized to the insulincontaining ␤-cells, somatostatin-containing ␦-cells, and glucagon-containing ␣-cells.
PST has an anti-insulin effect on hepatocytes and adipocytes but not in muscle cells (21) . It did not affect the insulinstimulated glucose metabolism in skeletal muscles (6, 21) . PST actions on hepatocytes and adipocytes were mediated by protein kinase C (PKC) activation (24, 57) . In humans, PST causes a direct decrease in glucose uptake by 50% while directly increasing the spillover of free fatty acids but not aa. PST levels are elevated in patients with Type 2 diabetes mellitus (47) . The chronic PST treatment showed decreased insulin sensitivity and caused insulin resistance in Chga knockout (KO) mouse (21, 41) .
According to the International Diabetes Federation, there are 366 million people living with diabetes in the world (36) . Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose concentration-hyperglycemia and occurs when the pancreas does not produce sufficient insulin or when the body cannot sensitize the effect of insulin it produces. Accordingly, diabetes is classified into two types: 1) Type 1 diabetes, caused by a deficiency of insulin resulting from autoimmune destruction of beta cells of the pancreas that produce insulin and regulate blood glucose; and 2) Type 2 diabetes, caused by loss of insulin sensitivity or insulin resistance with impaired insulin secretion resulting in relative insulin deficiency.
Glucose homeostasis involves essential components like liver, skeletal muscles, adipose tissue, and pancreatic endocrine islet cells. Glucose-stimulated insulin release is mediated by an increase in intracellular ATP causing depolarization of the cell membrane via inhibition of an ATP-regulating K ϩ channel. That results influx of calcium (Ca ϩ ) ions into the cell via opening of voltage-gated Ca ϩ ion channels, which triggers the release of insulin into the blood stream by the process of exocytosis (3, 4) . Insulin stimulates cells to absorb glucose (glucose uptake) from the blood into the liver, muscles, and fat tissues. In the liver and muscles, glucose is stored as glycogen, and in fat cells (adipocytes) it is stored as triglycerides.
PST inhibits the insulin-stimulated glucose uptake. Gly297Ser, a human PST variant, has a functionally important carboxy terminus of the peptide that increases the peptide's potency to inhibit cellular glucose uptake in rat adipocytes (47) . The emphasis of this review is to discuss the biological and metabolic effects of PST with the signaling mechanisms involved in glucose homeostasis.
PST ACTS AS DYSGLYCEMIC PEPTIDE

History of Discovery
PST, originally isolated from porcine pancreas in 1986 (80), inhibits glucose-stimulated insulin secretion from islet ␤-cells. Porcine PST consists of 49 aa (79) (5 kDa): Ala (8), Arg (3), Asp (1), Glu (13), Gly (9), His (1), Leu (1), Lys (2), Met (1), Phe (1), Pro (5), Ser (1), Thr (2), Trp (1). Soon after, in 1987 (12, 34, 37) , PST was found to be obtained from prohormone CHGA, which is an acidic glycoprotein present in secretory granules of the sympathetic adrenal system including neuroendocrine cells and gastrointestinal systems (81) . Now it is well known that enzymatic proteolysis of CHGA can produce a variety of regulatory peptides (82) , but PST was the first known biologically active peptide from the CHGA.
Structure and Molecular Forms of PST
PST (human sequence: GESRSEALAVDGAGKPGAEEAQD-PEGKGEQEHSQQKEEEEEMAVVPQGLFRG). PST shares the poly-glutamate sequence with gastrin and the COOH-terminal Arg-Gly-NH 2 with vasopressin (80) . Among the CHGA functional peptides, PST is the only peptide evolved in mammals as no homology could be detected in the submammalian vertebrates. However, in mammals, PST is fairly well conserved. The homology is 41.5% between the highest evolved humans and the Tasmanian devil, which ranks almost at the bottom of the mammalian phylogenetic tree (Fig. 2) . In primates, the Hominidae family (human, chimpanzee, gorilla, and gibbon) displays the best homology (Ͼ94%) with human PST followed by Parvorders Catarrhini (Ͼ78%; baboon, monkey, and macaque) and Platyrrhini (Ͼ70%; squirrel monkey, marmoset, and galago). The human PST is well conserved in nonprimates: Ͼ57% in rodents (rat, mouse, and hamster), Ͼ64% in carnivores (dog, cat, and walrus), Ͼ51% in artiodactyles (cow, pig, and sheep), Ͼ69% in cetaceans (whale and dolphins), Ͼ64% in perissodactyles (horse and rhinoceros), and 67% in sirenians (manatee) (Fig. 3) . Since PST antagonizes insulin action no homology was detected for PST in birds, as avian adipose tissue displays refractoriness to insulin action (10 (20, 35) , whereas bovine CHGA 248 -294 amide has been isolated from pancreas and pituitary (46) . Different phosphorylated forms of PST have been reported depending on the localization of the peptide (bovine pancreas or ileum) (84) .
Synthesis and Secretion of PST
The PST is a regulatory peptide found to be derived from CHGA, a prohormone for different active peptides. Proteolysis of CHGA occurs both inside and outside the cell to yield biologically active peptides (42) . The major indirect source of PST in plasma is chromaffin cells, which is the major source of circulating CHGA (76) .
The intracellular processing of CHGA for PST involves proteases such as prohormone convertase-2 (PC-2) and carboxypeptidase H (2, 83) . The extracellular processing of CHGA involves proteases cosecreted by the chromaffin granule to exoproteases localized on the extracellular side of the cell plasma membrane or to the proteases present in plasma. CHGA is fully processed in endocrine cells of pancreas and stomach, of which PST is a major product (28) . Higher PST production was observed in insulinoma cells compared with primary human islets. Somatostatin-secreting delta-cell line (QGP-1N) also releases PST. Enterochromaffin-like (ECL) cells, originating from the gastric antrum, represent the best characterized physiological system of PST secretion. These cells respond to gastrin stimulation by increasing both PST secretion and CHGA mRNA levels (27) . At carboxy termini, the cleavages are occurring with the actions of basic-residue recognizing prohormone convertases (13), followed by the peptide a-amidating mono-oxygenase (PAM). At amino termini, formation of bovine CHGA 259 -294 amide indicates cleavage at Gly 258 2Lys 259 was due to cathepsin L protease (86) . Formation of bovine CHGA 223-294 amide by cleavage at Ala 222 2Val 223 was also due to cathepsin-like specificity, while formation of bovine CHGA 220 -294 amide by cleavage at Arg 219 2Glu 220 indicates trypsin-like enzymes such as the prohormone convertases.
PST Formation in Hormone Storage
BIOLOGICAL EFFECTS OF PST ON GLANDULAR SECRETIONS
Endocrine Pancreas PST was initially described as an inhibitor of glucosestimulated insulin secretion from the porcine pancreas, especially the first phase of insulin secretion (80) and since confirmed in vitro and in vivo in the rat (17) . In cell line RIN m5F, PST has been found to significantly inhibit insulin secretion stimulated by glyceraldehydes, carbachol, or ionophore A23187 (32) , where secretory mechanism known to directly elevate ␤-cell cytosolic Ca 2ϩ (59) . PST was not found to inhibit insulin secretion stimulated by mastoparan and longer incubation (30 min) with phorbol myristate acetate ester (PMA), where the mechanisms are not Ca 2ϩ dependent (32) . These effects of PST were mainly due to the disruption of Ca 2ϩ -dependent events, mediated by G protein of the Gi family as a result of its pertussis toxin sensitivity. PST inhibits insulin release induced by various stimuli such as physiological (glucose, arginine) (11), hormonal [GIP, VIP, CCK-8 (49) and glucagon (11)], and even pharmacological (3-isobutyl-1-methylxanthine and sulphonylurea) (72) . In the rat perfused pancreas, PST did not affecting the somatostatin and glucagon release. The effects of PST may be species dependent, as PST had no effect on glucose-induced insulin release in the canine pancreas and pig in vivo (48) .
Exocrine Pancreas
PST slightly stimulates the amylase secretion from the exocrine porcine pancreas (1). PST has an inhibitory effect on exocrine pancreatic secretion in rats after in vivo physiological stimulation (meal) (43) , , and central vagal nerve stimulation (78) . This inhibitory effect of exocrine pancreatic secretion can be produced by human synthetic PST and a COOH-terminal fragment, bovine PST, porcine PST, and rat PST. Surprisingly, all four mammalian PSTs have the same biological activity as the homologous PST (74) . These effects seem to be mediated by presynaptic modulation of acetylcho- PANCREASTATIN AND GLUCOSE HOMEOSTASIS line release from vagal system, and therefore it has been proposed as a new mediator in islet-acinar axis (33) .
Gastric Secretion
The ECL cells of gastric antrum are an important source of PST-like immunoreactivity (PST-LI) and play a role in the paracrine regulation of gastric acid secretion (28) . PST inhibits gastric acid secretion from rabbit isolated parietal cells (38) but in vivo certainly enhances gastric acid secretion in the conscious dog after stimulated by peptone meal, phenylalanine, or glucose (30) . The mechanism involves inhibition of histamine stimulation of the parietal cell, which could be blocked by pertussis toxin, mediating inhibition on the intracellular cAMP levels (39, 40) .
Parathyroid Hormone Secretion
PST has an inhibitory effect on parathyroid hormone (PTH) in porcine (15) and bovine (9) parathyroid cells upon stimulation with either low calcium concentration or phorbol ester (nonphysiological), in accordance with the increase in PTH secretion when incubating parathyroid cells with anti-PST antibodies (14) . Moreover, the PST also inhibited the transcription of the PTH and CHGA genes and decreased the stability of the respective mRNAs (87) . Very abundant in the parathyroid gland, CHGA does not yield PST. This is due to the lack of prohormone convertases PC2 and PC1/3; complete processing of PST is rare, although processed PST is present in calcitonin-producing C cells, which have been proposed in the regulation of the thyroid-parathyroid axis.
PST EFFECTS ON GLUCOSE HOMEOSTASIS: IN VITRO AND IN VIVO STUDIES
Hepatic Glycogen Metabolism
In mouse primary hepatocytes, PST inhibits insulin-stimulated glucose uptake and increases hepatic glucose production (Fig. 5A) . In rat liver, PST has a calcium-dependent glycogenolytic effect. PST causes hyperglycemic effect by increasing glucose release from the liver (66) . PST has a direct effect on glycogen metabolism, which can be observed in rat in vivo, even without the modification of basal glucagon or insulin levels. The glycogenolytic effect of PST was confirmed by studies in rat isolated hepatocytes, which was mediated by cAMP-independent Ca 2ϩ -dependent mechanism (67). At 0.1 M, PST stimulated glycogenolysis by ϳ55% as much as did glucagon and by ϳ75% as much as did vasopressin, on the basis of equimolar concentrations.
In addition to its glycogenolytic effect, PST inhibited ϳ45% of the insulin-stimulated glycogen synthesis, and it enhanced the rate of glycolysis of insulin-stimulated hepatocytes ϳ25%. PST did not affect either basal rate of glycogen synthesis or basal rate of glycolysis (lactate production). However, the effect on insulin-stimulated glycolysis was observed only at high concentrations of PST and insulin (52) . These results suggest a role of PST in the possible mechanisms involved in insulin resistance.
Regulation of Cell Growth
PST found to have an inhibitory effect on cell growth and proliferation in pancreatic and HTC rat hepatoma cells. PST inhibits the protein and DNA synthesis in rat hepatoma cells. This inhibitory effect was mediated by nitric oxide (NO) and cyclic GMP (cGMP) production. PST also stimulates mitogenactivated protein kinase (MAPK) activity, which is responsible for cell growth. PST's dose-dependent increase of NO production overcame the effect of MAPK pathway (54) . The effect of PST on hepatocyte growth may depend on NO availability. If NO production is blocked, PST stimulates cell growth.
Action on Muscle Cells
PST failed to modulate the insulin sensitivity in L6 muscle cells (21) . The mechanism may involve elevation of adipokine levels that regulate glucose disposal independently of insulin. PST action on muscle cell line C2C12 is not yet reported.
Glucose Homeostasis in Adipocytes
PST has been found to have lipolytic and anti-insulin effects in white adipocytes. PST dose dependently inhibited basal and insulin-stimulated glucose transport, lactate production, and lipogenesis in adipocytes (53) . PST promotes energy expenditure by preventing the insulin action on energy metabolism. In contrast, PST enhanced basal and insulin-stimulated protein synthesis.
PST inhibited both basal and insulin-stimulated glucose transport. This effect was observed significant at 0.1 nM PST, and the IC 50 was 0.6 nM. PST (10 nM) inhibited ϳ50% of the insulin-stimulated glucose transport. This result was further supported by decreased glucose uptake in mouse primary adipocytes (Fig. 5B) (21) . PST inhibited lactate production at range of concentrations (10 -100 nM), with a slight effect on basal levels that may be due to the decrease in glucose uptake (53) .
Insulin increases the rate of lipid synthesis up to threefold, and PST reduced this effect by 25%. Lipogenesis was dependent on PST concentration, with a maximum observed at 10 nM and an IC 50 of Ϸ1 nM. Basal synthesis of lipids was not significantly affected by PST. PST has a lipolytic effect in rat adipocytes (7) (ED 50 0.1 nM), but it was completely inhibited by insulin. Insulin 10 nM completely inhibited the lipolytic effect of PST, which was determined by glycerol measurement (53) .
PST potentiates the effect of insulin-stimulated protein synthesis (Ϸ40%). This effect was dependent on the PST concentration with a maximal effect at 10 nM and an ED 50 of Ϸ1 nM. Furthermore, PST also stimulated basal protein synthesis in a dose-dependent manner, with a maximal effect at 10 nM (Ϸ30% increases) and an ED 50 of, 0.6 nM (53). The activation of ERK1/2 by ␤3-adrenergic receptor could mediate this action since it has been shown that the differentiation of fibroblasts to adipocytes requires the MAPK pathway. PST acts as a lipokinetic hormone and as an inhibitor of insulin action in rat adipocytes (53) .
Regulation of Leptin and Uncoupling Protein-2 Expression
Leptin is an adipocyte-secreted hormone that decreases energy intake and increases energy expenditure via the central nervous system, which has a role in energy homeostasis (45, 77) . Leptin expression is regulated by dietary status, insulin, glucocorticoids, and catecholamines. PST (100 nM) inhibited leptin expression at 16 h incubation by ϳ50%, but this effect was no longer observed after 24 h. PST (100 nM) also inhibited leptin secretion: a 30% decrease in leptin release was observed from control adipocytes (23) . Cycloheximide (protein synthesis inhibitor) at 20 mg/ml was employed to analyze the effect of PST on leptin secretion. PST doesn't modify the synthesized leptin release, but it inhibits leptin secretion from rat adipocytes by decreasing leptin mRNA expression. Inhibition of leptin production was supported by the results observed in mouse primary adipocytes (Fig. 5C ) and decreased plasma leptin levels in PST supplemented KO mice (Fig. 5D) (21) .
Uncoupling protein-1 (UCP-1) is mainly present in brown adipose tissue but is also present in white adipocytes, whereas UCP-2 is abundant in white adipose tissue (16) . PST stimulated the expression of UCP-2 mRNA for 16 h, ϳ100% over the control. This effect was significant after 24 h incubation http://physiolgenomics.physiology.org/ with a 50% increase over the control. These observations point out the significance of PST regulating energy balance on a long-term basis. PST stimulation of rat adipocytes for 16 and 24 h did not affect the UCP-1 expression and PPAR-␥ expression. PKC is involved in the upregulation of the UCP-2 expression. PKC also inhibits the expression and secretion of leptin (23) . The inhibitory effect of PST on leptin expression and secretion and the stimulation of UCP-2 expression were prevented by blocking PKC with 50 nM bisindolylmaleimide (23) .
MECHANISM OF ACTION OF PST
PST Signaling in Liver
PST receptors were purified and characterized in the liver, hepatoma membranes, as well as the signal transduction (55, 62, 63) . This receptor appears to mediate the dual signaling mechanism in liver (57) . PST stimulation activates pertussis toxin-insensitive G protein (G ␣q/11 ), leading to the activation of phospholipase C b3 isoform (PLC-b3) (69) , and therefore mediates the glycogenolytic effect in the liver by increasing cytoplasmic free calcium and stimulating PKC, while the pertussis toxin-sensitive G protein (G ai1,2 ) leads to the activation of guanylatecyclase (51) . In the signaling pathway, hydrolysis of phosphatidylinositol 4,5-bisphosphate by Ca 2ϩ -mobilizing hormones leads to the formation of two second messengers i.e., inositol-1,4,5-triphosphate (InsP3) and diacylglycerol (DAG). The primary function of InsP3 is to mobilize Ca 2ϩ from intracellular stores (60) , whereas DAG stimulates PKC (58) .
Active PST receptors were solubilized from rat liver membranes, and these results support the liver PST receptor consists of a 80 kDa glycoprotein physically associated with G ␣q/11 proteins (61, 70) . PST binding is sensitive to the presence of guanine nucleotides. Guanine nucleotides inhibited the PST binding to rat liver membranes, and the order of potency was GMP-P(NH)P Ͼ GTP Ͼ GDP (61) . Moreover, the effect of PST on DAG production seems to occur in the absence of GTP, as was observed in InsP3 production. GTP binding and photolabeling using specific antisera demonstrated a double system of G proteins coupled to PST receptor, a G ␣q/11 family, and, to a lesser extent, a G ␣i1,2 family (68, 71).
In HTC hepatoma cells, the proliferative effect observed was due to the PST activation of G ␣q/11 pathway leading to the phosphorylation of phospholipase C activity and the activation of MAPK pathway (55) . PST inhibits growth and proliferation by producing NO on HTC rat hepatoma cells. The NO and cGMP produced by the NO activated the guanylatecyclase pathway by activating the protein kinase G pathway. The cGMP production is secondary to the activation of guanylylcyclase by NO, which is produced by PST activation of endothelial nitric oxide synthase (eNOS), and to a lower extent, of neuronal nitric oxide synthase (8) . Moreover, PST dosedependently increased NO production in parallel to cGMP, and both effects were prevented by N-monomethyl-L-arginine (NMLA). The stimulatory effect of PST was also observed on DNA and protein synthesis, when the activity of NO synthase was blocked by NMLA. This effect was probably due to MAPK activation because it was prevented by PD98059 (54) .
PST might have two pathways for gluconeogenesis process, one by suppressing the PI 3-kinase-serine/threonine kinase (Akt)-forkhead transcription factor (FOXO-1)-sterol regulatory element-binding protein 1c (SREBP1c) pathway and the other by activating the eNOS pathway (Fig. 6) . The combined effects of cPKC and eNOS activation by PST can suppress insulin signaling. PST markedly suppressed insulin signaling through IRS1/2 and Akt phosphorylation, showed in Fig. 7, A and B . The antagonistic effects of PST on insulin signaling via the Akt/ FOXO-1 and SREBP1c gluconeogenic pathways are mediated by cPKC-dependent inactivation of PI 3-kinase activity (21) . PI 3-kinase activity is crucial for FOXO-1-and SREBP1c-mediated regulation of gluconeogenesis. PST administration attenuated phosphorylated FOXO-1 and SREBP1c signals. In addition to protein levels, PST restores gluconeogenic genes like phosphoenolpyruvate carboxykinase-1 gene (Pepck1) and glucose-6-phosphatase gene (G6pase) compared with KO mice (Fig. 7C) . These findings identify the novel role of PST in the regulation of gluconeogenic gene transcription by insulin.
PST Signaling in Adipocytes
Pharmacological characterization of PST receptors has been described in adipocyte membranes. Similarly in the adipocyte, PST receptor is also coupled to two G protein systems, G␣ q/11 
In vitro models
Chga KO mouse hepatocytes gluconeogenesis suppressing PI 3-kinase-Akt-FOXO-1 (SREBP1c) pathway and activating the eNOS pathway and G␣ i1,2 . Most of the PST receptors are coupled to a G␣ q/11 protein family that leads to the activation of the PLC-␤3 signaling pathway. G␣ i1,2 isoforms are activated by PST to a lesser extent in rat adipocyte membranes (26) . PST inhibits GLUT4 translocation (24) , glycogen synthesis, and leptin expression in the rat adipocyte membrane, mediated by PKC activation. PST inhibits glycogen synthesis by activating GSK-3 activity (25) . PST enhances the effect of insulin on protein synthesis, mediated by PKC pathway involved in regulation of the translation machinery: the activation of S6 kinase, the phosphorylation of the initiation factor eIF4E, and the phosphorylation of the eIF4E-binding protein, 4E-BP1 (PHAS-I) (22) . In adipocytes, the major insulin-stimulated PHAS-1 kinase is MAPK. PST potentiates the effect of insulinstimulated MAPK phosphorylation. In Chga KO mice, reduced lipolysis was observed due to decrease in lipogenic genes like sterol-regulatory elementbinding protein 1c gene (Srebp1c), peroxisome proliferatoractivated receptor gene (Ppar␥), and glycerol-3-phosphate acyltransferase gene (Gpat), represented in Fig. 7D . There was no significant change in fatty-acid synthase gene (Fasn) expression between wild-type (WT) and KO mice. However, hepatic triglyceride content was intact. This could be due to increased fatty acid-oxidation in KO mice as suggested by higher levels of ketone bodies, phosphorylated acetyl-CoA carboxylase, and UCP-2 gene (21).
DIABETIC ROLE OF PST IN HUMAN MODELS
PST in Human Arm Infusion
Effect on glucose metabolism. PST exerts significant, consistent, and substantial effect to decrease in glucose uptake up to 48 -50% of skeletal muscle in human beings in vivo. Due to lack of change in the forearm plasma flow of PST infusion, its effect on glucose uptake was metabolic rather than hemodynamic. Infusion of insulin at a local concentration increased forearm glucose uptake substantially, but PST did not reverse this insulin effect (6) .
Effect on fatty acid metabolism. Under basal conditions (vehicle infusion), there is a net spillover of free fatty acid efflux from the forearm into the circulation, and this spillover was increased by PST (4.5-to 6.4-fold). During insulin infusion, free fatty acid metabolism transitioned spillover toward uptake. But PST did not reverse the insulin effect. These results were correlated with the lipolytic activity of PST in isolated rat adipocytes, although it was completely inhibited by insulin (47) .
Effect on aa metabolism. During vehicle infusion, 17 out of 20 natural aa in plasma showed net spillover from the forearm into circulation. But PST had no effect on this process for any of the 20 natural aa (47) . While insulin infusion decreased significantly spillover of two natural aa (Ala and Asp), ornithine and PST did not reverse the insulin-induced aa uptake.
PST and Human Disease
Inhibition of insulin release is well known biological activity of PST. However, extrapancreatic effects have been explained, such as the inhibition of parathormone secretion, the stimulation of hepatic glycogenolysis, or the inhibition of catecholamine release. The biological and metabolic effects of PST and its mechanisms are listed in Table 1 . PST was elevated and overexpressed in Type 2 diabetes mellitus (47) .
In essential hypertensive patients, significant positive correlations between plasma PST-LI and norepinephrine (NE) levels were reported (64) . PST is stored with catecholamines in peripheral sympathetic nerves as the prohormone CHGA, which is co-released with catecholamines after sympathetic stimulation. Venous plasma PST-LI may reflect sympathetic nerve activity in essential hypertension.
Sánchez-Margalet et al. (65) studied a group of nonobese hypertensive subjects in which PST-like peptide levels were increased compared with controls and correlated with NE http://physiolgenomics.physiology.org/ levels. PST in combination with the sympathoadrenal system might have a part in the insulin resistance of these patients, and this metabolic syndrome could play a role in the pathogenesis and complications of hypertension. All hypertensive patients showed an increase in plasma PST levels after glucose loading. The increase in PST levels was in the order of normoinsulinemic Ͼ hyperinsulinemic Ͼ glucose-tolerant patients (65) .
Counterregulatory hormone levels (catecholamine and PST-LI levels) were found elevated in gestational diabetic subjects compared with pregnant control subjects and nonpregnant women. Plasma PST-LI levels were found to be significantly elevated in the gestational diabetic group (46 Ϯ 2 vs. 30 Ϯ 2 pmol/l), whereas PST-LI levels in control subjects were similar to those third-trimester normal pregnant women (56) .
Plasma PST levels in noninsulin-dependent diabetes mellitus (NIDDM) patients elevated significantly after glucose ingestion. The small significant rise of plasma PST after glucose ingestion in NIDDM patients may suggest a hypersensitivity of PST-producing cells to glucose in the pancreas. These results suggest that the hypersecretion of PST in NIDDM patients may act on inhibition of glucose-stimulated insulin secretion and induce hyperglycemia (19) .
Nonsecreting pituitary adenomas, frequently associated with diabetes mellitus, arise quasiconstantly from gonadotroph cells. PST was significantly (P Ͻ 0.05) higher before (391 Ϯ 65 pg/ml) than after trans-sphenoidal surgery (149 Ϯ 18 pg/ml) without postsurgical change in diabetes (50) . An immunostaining against PST was reported in a majority of pituitary adenomas, associated or not with diabetes mellitus. These results suggest a role of PST in the pathogenesis of diabetes mellitus associated with nonsecreting pituitary adenomas.
Human PST Variants and Their Potency: In Vitro Studies
Genomic DNA was isolated from 180 individuals (n ϭ 360 chromosomes) of four ethnic/ancestry groups (by self-identification: white/European, African-American, East Asian, and Mexican American) for resequencing at the CHGA locus and revealed three naturally occurring PST aa variants: Arg253Trp (RKGESWSEALAVDGAGKPGAEEAQDPEGKGEQEHS-QQKEEEE-EMAVVPQGLFRG), Ala256Gly (RKGESRSE-GLAVDGAGKPGAEEAQDPEGKGEQEHSQQKEEEEE-MAVVPQGLFRG), and Gly297Ser (RKGESRSEALAV-DGAGKPGAEEAQDPEGKGEQEHSQQKEEEEEMAV-VPQSLFRG). Gly297Ser variant lies in the comparatively conserved carboxy-terminal region, although the bovine residue (Val) at that position differs from the otherwise conserved Gly (in mice, rat, porcine, and human sequences). The other two human variants, Arg253Trp and Ala256Gly toward the amino terminus, are in an unconserved region (47) .
Synthetic WT human PST (CHGA 273-301 amide; PEG-KGEQEHSQQKEEEEEMAVVPQGLFRG amide) and its Gly297Ser variant were tested for dose-dependent inhibition of insulin-stimulated glucose uptake in rat adipocytes, using the nonmetabolizable substrate 2-deoxyglucose. Both WT and Gly297Ser variant PST inhibited insulin-induced 2-deoxy glucose uptake, while the Gly297Ser variant unexpectedly exhibited increased potency, with substantially greater inhibition of substrate transport, especially at relatively low peptide doses. The IC 50 value for WT human PST was Ϸ600 pM, while that for Gly297Ser was Ϸ100 pM (47).
In rat adipocyte primary culture, at a higher dose (ϭ 10 Ϫ8 M), Gly297Ser decreased glucose uptake to 72.0 Ϯ 3.9% of control compared with 82.1 Ϯ 4.3% of WT human PST. Rat PST decreased glucose uptake to 68.2 Ϯ 3.2% of control, a value comparable to human Gly297Ser (47) . In Chga KO mice, human PST variant (Gly297Ser) was found to reduce insulin response to a lesser extent and at twice the dose compared with WT-PST (21).
CONCLUSION AND PERSPECTIVES
Studies have documented that the CHGA-derived peptide PST acts as an anti-insulin agent. PST diminishes insulin sensitivity and impairs glucose homeostasis. In hepatocytes and adipocytes, PST receptor is coupled to two G protein systems, G␣ q/11 and G␣ i1,2 . Most of the PST receptors are coupled to a G␣ q/11 protein family that leads to the activation of the PLC-␤3 signaling pathway. G␣ i1,2 isoforms are activated by PST to a lesser extent. In gluconeogenesis, PST attenuated phosphorylated FOXO-1 and SREBP1c signals, activating the eNOS pathway. PST's overall effect on carbohydrate and lipid metabolism is pictorially represented in Fig. 8 . Elevated PST plasma levels are observed in Type 2 diabetes, essential hypertensive patients, gestational diabetic subjects, and nonsecreting pituitary adenomas associated with diabetes mellitus. The effect of PST on the incretin signaling pathway of glucose homeostasis yet to be explored. It would be of interest to investigate the effect of PST on the pathogenesis (biomarker) and treatment of Type 2 diabetes (drug discovery). 
